MedEquities Realty Trust Inc (MRT) Director Bluemountain Capital Managemen Sells 21,601 Shares

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 21,601 shares of the firm’s stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $7.05, for a total transaction of $152,287.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Friday, November 23rd, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.15, for a total transaction of $71,500.00.
  • On Monday, November 26th, Bluemountain Capital Managemen sold 15,607 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.16, for a total transaction of $111,746.12.
  • On Wednesday, November 21st, Bluemountain Capital Managemen sold 7,200 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.16, for a total transaction of $51,552.00.
  • On Monday, November 19th, Bluemountain Capital Managemen sold 1,514 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.48, for a total transaction of $11,324.72.
  • On Friday, November 16th, Bluemountain Capital Managemen sold 28,027 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.52, for a total transaction of $210,763.04.
  • On Wednesday, November 14th, Bluemountain Capital Managemen sold 57,234 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.81, for a total transaction of $446,997.54.
  • On Monday, November 12th, Bluemountain Capital Managemen sold 37,530 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.74, for a total transaction of $328,012.20.
  • On Thursday, November 8th, Bluemountain Capital Managemen sold 35,783 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.60, for a total transaction of $307,733.80.
  • On Tuesday, November 6th, Bluemountain Capital Managemen sold 25,765 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.58, for a total transaction of $221,063.70.
  • On Friday, November 2nd, Bluemountain Capital Managemen sold 25,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total transaction of $209,750.00.

Shares of MRT stock opened at $6.84 on Friday. MedEquities Realty Trust Inc has a 12-month low of $6.81 and a 12-month high of $12.00. The stock has a market cap of $223.99 million, a P/E ratio of 6.22 and a beta of 0.65.

MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings results on Monday, November 12th. The financial services provider reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.25). MedEquities Realty Trust had a net margin of 19.98% and a return on equity of 3.39%. The firm had revenue of $9.68 million for the quarter, compared to the consensus estimate of $17.72 million. On average, equities analysts predict that MedEquities Realty Trust Inc will post 0.8 earnings per share for the current fiscal year.

Hedge funds have recently made changes to their positions in the stock. Los Angeles Capital Management & Equity Research Inc. bought a new position in MedEquities Realty Trust during the 2nd quarter valued at about $131,000. People s United Financial Inc. bought a new position in MedEquities Realty Trust during the 2nd quarter valued at about $158,000. Bank of Montreal Can bought a new position in MedEquities Realty Trust during the 2nd quarter valued at about $160,000. California Public Employees Retirement System bought a new position in MedEquities Realty Trust during the 2nd quarter valued at about $171,000. Finally, Raymond James Trust N.A. bought a new position in MedEquities Realty Trust during the 3rd quarter valued at about $161,000. 90.81% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have recently commented on the stock. B. Riley set a $12.00 price objective on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a report on Thursday, August 9th. ValuEngine downgraded shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a report on Friday, September 14th. Raymond James reduced their price objective on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “buy” rating for the company in a report on Tuesday, November 20th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $10.00 price objective (down from $12.00) on shares of MedEquities Realty Trust in a report on Friday, September 28th. Finally, Canaccord Genuity reduced their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, August 9th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $11.00.

TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.com-unik.info/2018/12/01/medequities-realty-trust-inc-mrt-director-bluemountain-capital-managemen-sells-21601-shares.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Read More: The Structure of a Futures Contract

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit